{
event: "view_event",
interaction_type: "calendar",
name: `ATTD - Advanced Technologies & Treatments for Diabetes`,
event_type: `3rd Party Registration`,
event_category: 'Congress, All Events',
date: `Mar 11, 2026, 1:00:00 PM - Mar 11, 2026, 6:00:00 PM`,
}
Successfully Registered.
Registration Failed
Congress | All Events
ATTD - Advanced Technologies & Treatments for Diabetes
5 hours
The symposium addresses various topics within the area of T1D screening and management; from early (timely) screening, testing, and diagnosis, through to early interventions. Each section focuses on a stage within this continuum, highlighting the importance of early identification, key considerations around communication and psychosocial care, monitoring strategies, and the current landscape of disease-modifying therapies.
Illustrate the T1D care journey from screening and diagnosis through to monitoring and management using role-played scenarios
Highlight the real-world burden of T1D disease, emphasizing the clinical importance of T1D screening and early detection
Review current technology driving T1D screening, monitoring, and management
Ultimately reflect on key decision points in the T1D care journey, identify next steps, and discuss available management options through discussion of current and investigational therapeutic options
Welcome to BR1DGE
BR1DGE is a non-promotional global medical education program designed to advance understanding around presymptomatic type 1 diabetes and is provided by Sanofi.
This website is intended only for use by healthcare professionals in Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, Kingdom of Saudi Arabia, Kuwait, Luxembourg, Mexico, Norway, Poland, Portugal, Qatar, Russian Federation, Spain, Sweden, The Netherlands, The United Arab Emirates, and The United Kingdom (UK).
Note: Healthcare professionals from Ireland or The UK must click the second link below to be redirected to the local website.
Are you a healthcare professional from one of the countries listed above?
You are now being redirected to a third-party website.
You are now being redirected to a third-party website.
You are about to leave the Sanofi-sponsored BR1DGE website and enter a third-party website. This link is provided as a service and does not imply endorsement by Sanofi of the information contained on the third-party website. Sanofi is not responsible for the content, views, or privacy policies of this third-party site.
